Genprex Correlations
| GNPX Stock | USD 2.20 0.24 12.24% |
The current 90-days correlation between Genprex and GRI Bio is 0.14 (i.e., Average diversification). The correlation of Genprex is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Genprex Correlation With Market
Excellent diversification
The correlation between Genprex and DJI is -0.55 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Genprex and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Genprex Stock
| 0.77 | EDIT | Editas Medicine | PairCorr |
| 0.66 | EVGN | Evogene | PairCorr |
| 0.81 | QSI | QuantumSi | PairCorr |
| 0.67 | GNLX | Genelux Common | PairCorr |
| 0.75 | IMRN | Immuron Ltd ADR | PairCorr |
| 0.61 | MBIO | Mustang Bio | PairCorr |
| 0.77 | ACXP | Acurx Pharmaceuticals LLC | PairCorr |
Moving against Genprex Stock
| 0.75 | DSGN | Design Therapeutics | PairCorr |
| 0.73 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.55 | ENGN | enGene Holdings Common | PairCorr |
| 0.51 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.46 | 63E | ONWARD MEDICAL BV | PairCorr |
| 0.74 | AVE | Avecho Biotechnology | PairCorr |
| 0.67 | ANNX | Annexon | PairCorr |
| 0.66 | SLDB | Solid Biosciences LLC | PairCorr |
| 0.64 | SVRA | Savara Inc | PairCorr |
| 0.61 | MRKR | Marker Therapeutics | PairCorr |
| 0.44 | BOLT | Bolt Biotherapeutics | PairCorr |
| 0.41 | BCAX | Bicara Therapeutics | PairCorr |
| 0.36 | RCKT | Rocket Pharmaceuticals | PairCorr |
| 0.69 | CAPR | Capricor Therapeutics | PairCorr |
| 0.68 | SMFG | Sumitomo Mitsui Financial Normal Trading | PairCorr |
| 0.68 | SMFNF | Sumitomo Mitsui Financial Normal Trading | PairCorr |
| 0.66 | FCAP | First Capital | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Genprex Stock performing well and Genprex Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Genprex's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| INM | 4.30 | (0.88) | 0.00 | (0.59) | 0.00 | 7.48 | 30.84 | |||
| LIMN | 8.49 | 1.37 | 0.12 | (0.45) | 8.09 | 33.64 | 97.96 | |||
| BDRX | 8.76 | (1.06) | 0.00 | (0.49) | 0.00 | 11.45 | 128.35 | |||
| CERO | 7.93 | (0.91) | 0.00 | (1.09) | 0.00 | 20.00 | 49.80 | |||
| JAGX | 7.28 | (0.96) | 0.00 | (0.18) | 0.00 | 10.14 | 125.57 | |||
| GRI | 7.89 | (3.53) | 0.00 | 10.98 | 0.00 | 11.88 | 77.14 | |||
| BIVI | 3.38 | (0.55) | 0.00 | (0.15) | 0.00 | 7.41 | 23.28 | |||
| CNSP | 3.49 | (0.62) | 0.00 | (0.69) | 0.00 | 7.22 | 31.54 | |||
| TOVX | 5.67 | (0.73) | 0.00 | (0.12) | 0.00 | 10.53 | 34.29 | |||
| CMMB | 3.40 | (0.75) | 0.00 | 0.95 | 0.00 | 7.74 | 21.53 |
Genprex Corporate Management
| CMA CPA | Co Controller | Profile | |
| Celina Laney | Chief Staff | Profile | |
| David Schloss | Senior Resources | Profile | |
| William Gannon | Member Affairs | Profile | |
| CPM EMBA | Chief Officer | Profile | |
| Kalyn Dabbs | Sr Marketing | Profile |